Therapeutic vaccines for allergic disease
Abstract Allergic diseases are highly prevalent worldwide and affect all age groups, contributing to a high personal and socioeconomic burden. Treatment with an “allergy vaccine” or allergen immunotherapy aims to provide long-lasting benefits by inducing unresponsiveness to the relevant antigen. The...
Guardado en:
Autores principales: | Danuta Gutowska-Owsiak, Graham S. Ogg |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/94a5bc1adc39429493086bc6f92391b2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Preclinical study of a novel therapeutic vaccine for recurrent respiratory papillomatosis
por: Maxwell Y. Lee, et al.
Publicado: (2021) -
Development of a therapeutic vaccine targeting Merkel cell polyomavirus capsid protein VP1 against Merkel cell carcinoma
por: Dan Xu, et al.
Publicado: (2021) -
Vaccines for human fungal diseases: close but still a long way to go
por: Lorena V. N. Oliveira, et al.
Publicado: (2021) -
Vaccine-induced, but not natural immunity, against the Streptococcal inhibitor of complement protects against invasive disease
por: Lionel K. K. Tan, et al.
Publicado: (2021) -
Quality by design modelling to support rapid RNA vaccine production against emerging infectious diseases
por: Damien van de Berg, et al.
Publicado: (2021)